Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul:66:28-40.
doi: 10.1016/j.bpobgyn.2019.12.002. Epub 2019 Dec 20.

Long-acting reversible contraceptive (LARCs) methods

Affiliations
Review

Long-acting reversible contraceptive (LARCs) methods

Luis Bahamondes et al. Best Pract Res Clin Obstet Gynaecol. 2020 Jul.

Abstract

Unplanned pregnancy (UP) is a public health problem, which affects millions of women worldwide. Providing long-acting reversible contraceptive (LARC) methods is an excellent strategy to avoid or at least reduce UP, because the effectiveness of these methods is higher than other methods, and is indeed comparable to that of permanent contraception. As the initial introduction of the inert plastic intrauterine device (IUD) and of the six-rod implant, pharmaceutical companies have introduced a copper IUD (Cu-IUD), different models of levonorgestrel-releasing intrauterine system (LNG IUS), and one and two-rod implants, which certainly improved women's LARC options. The main characteristic of LARCs is that they provide high contraceptive effectiveness with a single intervention, and that they can be used for a long time. Emerging evidence from the last few years has demonstrated that it is possible to extend the use of the 52 mg LNG IUS and of the etonogestrel-implant beyond five- and three years, respectively, which adds new value to these LARCs.

Keywords: Contraception; Copper intrauterine device; LARCs; Levonorgestrel-releasing intrauterine system; Long acting contraceptives; Subdermal implants.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest LB and IM have received honoraria as members of advisory boards and have been invited as speakers at scientific meetings for Bayer Healthcare Pharmaceuticals and Merck. None of the other authors have any conflicts of interest to declare.

Similar articles

Cited by

LinkOut - more resources